Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$222,135
New position
Shares Held
1,318
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#590
of 774 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MCGUIRE CAPITAL ADVISORS INC holds $912,196 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
14,872 | $610,198 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,318 | $222,135 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,422 | $76,544 | |
| 4 | VTRS |
Viatris Inc
|
164 | $2,604 | |
| 5 | CRON |
Cronos Group Inc.
|
130 | $361 | |
| 6 | ACB |
Aurora Cannabis Inc
|
69 | $192 | |
| 7 | OGI |
Organigram Global Inc.
|
100 | $102 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
10 | $44 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,135 | 1,318 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||